Jiali Zhao
52 Mei Hua East Road
Zhuhai, 519000, China
Zhuhai, 519000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
High Expression of Follistatin is a Risk Factor Predicting Poor Overall Survival in Hepatocellular Carcinoma Patients.
Journal: Journal of hepatocellular carcinoma
Published: February 15, 2026
Examination of the toxicity of a new group of Karenia papilionacea isolated from the Yellow Sea, China, to multiple species of marine aquatic animals.
Journal: Frontiers in microbiology
Published: August 16, 2025
CHAF1B: the hidden culprit behind sorafenib resistance in hepatocellular carcinoma.
Journal: International journal of medical sciences
Published: May 29, 2025
CAT and CXCL8 are crucial cofactors for the progression of nonalcoholic steatohepatitis to hepatocellular carcinoma, the immune infiltration and prognosis of hepatocellular carcinoma.
Journal: Discover oncology
Published: November 03, 2024
Knockdown of RASD1 improves MASLD progression by inhibiting the PI3K/AKT/mTOR pathway.
Journal: Lipids in health and disease
Published: October 29, 2024
Fibroblast activation protein peptide-targeted NIR-I/II fluorescence imaging for stable and functional detection of hepatocellular carcinoma.
Journal: European journal of nuclear medicine and molecular imaging
Published: September 24, 2024
Combined HIF-1α and SHH Up-Regulation Is a Potential Biomarker to Predict Poor Prognosis in Postoperative Hepatocellular Carcinoma.
Journal: Journal of investigative surgery : the official journal of the Academy of Surgical Research
Published: June 29, 2022
Combined Treatment of Tanshinone I and Epirubicin Revealed Enhanced Inhibition of Hepatocellular Carcinoma by Targeting PI3K/AKT/HIF-1α.
Journal: Drug design, development and therapy
Published: February 01, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026